BIPH:OTO-Biophan Techs Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | OTC Pink

Last Closing

USD 16.9

Change

0.00 (0.00)%

Market Cap

USD 0.19M

Volume

6.14K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Biophan Technologies Inc develops and markets cutting-edge technologies for the medical device industry. It develops biomedical devices that improve the delivery of healthcare.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

+1.89 (+0.82%)

USD 66.90B
ALC Alcon AG

-0.05 (-0.06%)

USD 38.91B
HYB New America High Income Closed..

+0.01 (+0.14%)

USD 35.93B
RMD ResMed Inc

-0.87 (-0.40%)

USD 27.76B
WST West Pharmaceutical Services I..

-6.02 (-1.67%)

USD 27.24B
BAX Baxter International Inc

+0.51 (+1.27%)

USD 20.44B
TFX Teleflex Incorporated

+1.77 (+0.86%)

USD 10.10B
ATR AptarGroup Inc

+3.05 (+2.13%)

USD 9.48B
STVN Stevanato Group SpA

-0.12 (-0.44%)

USD 7.29B
BLCO Bausch + Lomb Corp

+0.33 (+2.23%)

USD 5.19B

ETFs Containing BIPH

DFEN:XETRA VanEck Defense ETF A USD .. 7.52 % 0.00 %

+0.13 (+0.60%)

USD 0.53B
DFNS:SW VanEck Defense ETF A USD .. 7.52 % 0.00 %

+0.13 (+0.60%)

USD 0.53B
ASWC:XETRA HANetf ICAV - Future of D.. 5.11 % 0.00 %

+0.06 (+0.60%)

USD 0.30B
C40:SW Amundi Index Solutions - .. 4.80 % 0.00 %

-0.12 (0.60%)

USD 0.99B
C4DE:SW Amundi Index Solutions - .. 4.80 % 0.00 %

-0.06 (0.60%)

USD 0.02B
STQX:SW SPDR® MSCI Europe Indust.. 4.05 % 0.00 %

N/A

USD 0.30B
EWQ iShares MSCI France ETF 3.83 % 0.47 %

-0.07 (0.60%)

USD 0.64B
GOAT:LSE VanEck Morningstar Global.. 2.18 % 0.00 %

+0.14 (+0.60%)

USD 0.07B
GOGB:LSE VanEck Morningstar Global.. 2.17 % 0.00 %

+0.01 (+0.60%)

USD 0.06B
ELOW:SW SPDR® EURO STOXX Low Vol.. 1.21 % 0.00 %

+0.12 (+0.60%)

USD 0.02B
BDIV:CA Brompton Global Dividend .. 0.00 % 0.96 %

-0.12 (0.60%)

CAD 0.08B
CACX:LSE Lyxor CAC 40 (DR) UCITS E.. 0.00 % 0.00 %

-50.00 (0.60%)

USD 3.66B
IDJG:LSE iShares EURO Total Market.. 0.00 % 0.00 %

-61.00 (0.60%)

USD 0.29B
ISFR:LSE iShares MSCI France UCITS 0.00 % 0.00 %

-35.25 (0.60%)

USD 0.10B
NDUS:LSE SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

-0.15 (0.60%)

USD 0.18M
LOWE:LSE SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.03B
C40:PA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.26 (0.60%)

USD 0.97B
CAC:PA Lyxor UCITS CAC 40 (DR) D.. 0.00 % 0.00 %

-0.23 (0.60%)

USD 3.47B
CACC:PA Lyxor CAC 40 (DR) UCITS E.. 0.00 % 0.00 %

-0.11 (0.60%)

USD 0.26B
E40:PA BNP Paribas Easy CAC 40®.. 0.00 % 0.00 %

-0.03 (0.60%)

USD 0.31B
GWT:PA Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

+0.06 (+0.60%)

USD 0.19B
STQ:PA SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

-0.10 (0.60%)

USD 0.30B
EXH4:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

+0.02 (+0.60%)

USD 0.19B
GC40:F Amundi Index Solutions - .. 0.00 % 0.00 %

-0.42 (0.60%)

USD 0.91B
IQQG:F iShares Public Limited Co.. 0.00 % 0.00 %

-0.54 (0.60%)

USD 0.27B
IS3U:F iShares IV Public Limited.. 0.00 % 0.00 %

-0.22 (0.60%)

USD 0.10B
LGWT:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

-0.88 (0.60%)

USD 0.20B
SPYQ:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

-0.25 (0.60%)

USD 0.30B
DX2G:XETRA Xtrackers - CAC 40 UCITS .. 0.00 % 0.00 %

-0.33 (0.60%)

USD 0.12B
EXH4:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

+0.02 (+0.60%)

USD 0.16B
GC40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.30 (0.60%)

USD 0.91B
IQQG:XETRA iShares EURO Total Market.. 0.00 % 0.00 %

-0.46 (0.60%)

USD 0.29B
IS3U:XETRA iShares MSCI France UCITS 0.00 % 0.00 %

-0.19 (0.60%)

USD 0.11B
LGWT:XETRA Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

-0.08 (0.60%)

USD 0.20B
SPYQ:XETRA SPDR® MSCI Europe Indust.. 0.00 % 0.00 %

-0.15 (0.60%)

USD 0.31B
C4D:PA Amundi Index Solutions - .. 0.00 % 0.00 %

-0.24 (0.60%)

USD 0.02B
ESIN:LSE iShares MSCI Europe Indus.. 0.00 % 0.00 %

-0.02 (0.60%)

USD 0.16B
ESIN:F Ishares VI PLC - Ishares .. 0.00 % 0.00 %

-0.01 (0.60%)

USD 0.16B
ESIN:XETRA Ishares VI PLC - Ishares .. 0.00 % 0.00 %

+0.01 (+0.60%)

USD 0.16B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.72% 63% D 56% F
Dividend Return 1.86% 100% F 78% C+
Total Return 2.58% 68% D+ 61% D-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return 3.70% 90% A- 55% F
Total Return 3.70% 63% D 42% F
Trailing 5 Years  
Capital Gain N/A 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A 100% F 100% F
Average Annual (5 Year Horizon)  
Capital Gain 73,598.23% 100% F 100% F
Dividend Return 73,600.29% 100% F 100% F
Total Return 2.06% 89% A- 48% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 6% D- N/A F
Risk Adjusted Return 31.72% 61% D- 55% F
Market Capitalization 0.19M 5% F N/A F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.